PrEP and MOUD Rapid Access for Persons who Inject Drugs: the CHORUS+ Study
Project Number5R01DA058367-02
Contact PI/Project LeaderASSOUMOU, SABRINA A
Awardee OrganizationBOSTON MEDICAL CENTER
Description
Abstract Text
PROJECT SUMMARY / ABSTRACT
The US opioid overdose epidemic has been accompanied by an increase in human immunodeficiency (HIV)
among persons who inject drugs. The co-occurrence of HIV and opioid use disorder (OUD) suggests that a
comprehensive approach to OUD and its infectious complications has the potential to improve outcomes. HIV
pre-exposure prophylaxis (PrEP) and medication for opioid use disorder (MOUD) are evidence-based
approaches that are recommended for persons who inject drugs. Unfortunately, these measures have not
been widely adopted in real-world settings or accessed by persons at-risk. Foundation for the Proposal: The
CHORUS intervention (Comprehensive HIV and Opioid use disorder Response to the Unaddressed Syndemic)
is informed by preliminary research, including: (a) quantitative and qualitative research with persons with
substance use disorder, (b) a randomized controlled trial of a peer-delivered motivational intervention
demonstrating effectiveness in reducing heroin and/or cocaine use, and (c) preliminary studies demonstrating
the feasibility and acceptability of peer-delivered motivational interventions in non-traditional settings. During
the CHORUS pilot phase, we uncovered that PrEP was initiated late in the intervention. Therefore, we are
attempting to accelerate PrEP initiation by providing HIV self-testing (CHORUS +) at baseline. The CHORUS+
intervention includes HIV self-testing, rapid initiation of PrEP and MOUD, and a 6-month peer recovery coach
to support adherence to these medications. Conceptual Model: CHORUS+ is a theory-based, peer-delivered,
mobile phone-supported intervention focused on enhancing uptake and adherence to HIV PrEP (primary
outcome), and receipt of MOUD (secondary outcome) among persons who inject opioids. CHORUS+ aims to
improve behavioral skills and self-efficacy while addressing structural barriers. Summary: The current proposal
seeks to determine the efficacy of a novel intervention to increase the uptake of evidence-based measures to
prevent HIV and treat opioid use disorder. We will compare the CHORUS+ intervention to usual care (passive
referral) among persons who inject opioids (aim 1). In addition, we will examine study implementation to
facilitate potential future dissemination using a mixed-methods process evaluation of CHORUS+ (aim 2). The
study will be performed at Boston Medical Center’s Faster Paths clinic, a low-barrier substance use disorder
bridge clinic, and through Victory Programs, which utilizes a mobile outreach van. The proposed intervention
will recruit from non-traditional settings in order to reach participants who might not be comfortable in office-
based clinics. This project specifically addresses NIDA’s mission of developing effective socio-behavioral
interventions to increase uptake of HIV prevention strategies, and accelerating the adoption of evidence-based
interventions to address substance use and its infectious complications.
Public Health Relevance Statement
PROJECT NARRATIVE
This project is relevant to public health because it will determine the efficacy of an intervention providing HIV
prevention alongside treatment for opioid use disorder. The availability of HIV self-testing and pre-exposure
prophylaxis (PrEP) make it imperative to develop and implement interventions to increase their uptake.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAccelerationAddressAdherenceAdoptedAdoptionAffectAutomobile DrivingBehavior TherapyBehavioralBiometryBloodBostonBuprenorphineCaringCellular PhoneClinicClinical Laboratory Improvement AmendmentsCommunicable DiseasesCommunitiesControl GroupsCountyDataDiphosphatesDoseDrug userDrynessEffectivenessEnrollmentEpidemicEvaluationEvidence based interventionFoundationsFutureGoalsHIVHIV riskHomeHumanHuman immunodeficiency virus testIndividualInfectionInjecting drug userInterventionLaboratoriesMeasuresMedicalMedical centerMethadoneMethodsMissionModelingNational Institute of Drug AbuseOpioidOutcomeOverdoseParticipantPatientsPersonsPharmaceutical PreparationsPharmacy facilityPhasePilot ProjectsPopulationPopulations at RiskPrevention strategyPrivacyPublic HealthQualitative MethodsQualitative ResearchRandomizedRandomized, Controlled TrialsRecommendationRecordsRecoveryResearchResearch MethodologySelf EfficacySelf PerceptionSiteSocial BehaviorSpottingsSubstance Use DisorderTenofovirTestingTrainingTreatment EfficacyUnited States National Institutes of HealthVenous blood samplingWalkingacceptability and feasibilityaddictionarmcare fragmentationcocaine usecontextual factorsefficacy evaluationevidence baseexperimental studyheroin useimmunodeficiencyimprovedimproved outcomeinformantinterestlong term recoverymedication for opioid use disordermortalitymotivational enhancement therapymotivational interventionmultidisciplinarynovelopioid epidemicopioid overdoseopioid use disorderoutreachparticipant interviewpeerpeer coachingpeer recoverypilot testpoint of carepre-exposure prophylaxispreventprimary outcomeprocess evaluationprogramsrapid testrapid testingrecruitresponsescale upsecondary outcomeself testingskillssocial stigmasubstance usesyndemictheoriestherapy developmenttreatment as usualtrial designuptake
No Sub Projects information available for 5R01DA058367-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DA058367-02
Patents
No Patents information available for 5R01DA058367-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DA058367-02
Clinical Studies
No Clinical Studies information available for 5R01DA058367-02
News and More
Related News Releases
No news release information available for 5R01DA058367-02
History
No Historical information available for 5R01DA058367-02
Similar Projects
No Similar Projects information available for 5R01DA058367-02